Literature DB >> 11573991

Age-related changes in the N-methyl-D-aspartate receptor binding sites within the human basal ganglia.

J C Villares1, J N Stavale.   

Abstract

The present study examined the regional differences in dopamine transporter binding sites and NMDA receptor complex binding based on autoradiographic images obtained in postmortem sections of human normal brain tissues. In middle-aged control tissues, high and comparable levels of [(3)H]CFT binding were observed in the caudate nucleus, putamen, and accumbens nucleus without significant alteration along the rostrocaudal axis and ventral and dorsal parts of these nuclei. In aging normal brain tissues, dopamine binding sites for [(3)H]CFT were significantly reduced in the caudate nucleus, putamen, and accumbens nucleus. l-[(3)H]Glutamate, [(3)H]MK-801, and [(3)H]glycine binding to the NMDA receptor complex was lower in aging brain tissues than in middle-aged controls. Significant correlation did occur between age and [(3)H]CFT binding and between age and l-[(3)H]glutamate, [(3)H]MK-801, and [(3)H]glycine binding sites. These results demonstrate that the basal ganglia have age-associated reductions in dopamine transporter uptake and NMDA receptors. These data support hypoactive activity of the NMDA receptor complex system with advancing age. The dopamine transporter uptake and NMDA receptors appear to be vulnerable to the aging process in the basal ganglia. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11573991     DOI: 10.1006/exnr.2001.7737

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  7 in total

1.  Prescription use disorders in older adults.

Authors:  Raj K Kalapatapu; Maria A Sullivan
Journal:  Am J Addict       Date:  2010-09-21

2.  Low striatal glutamate levels underlie cognitive decline in the elderly: evidence from in vivo molecular spectroscopy.

Authors:  Natalie M Zahr; Dirk Mayer; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Cereb Cortex       Date:  2008-01-29       Impact factor: 5.357

3.  In vivo glutamate measured with magnetic resonance spectroscopy: behavioral correlates in aging.

Authors:  Natalie M Zahr; Dirk Mayer; Torsten Rohlfing; Sandra Chanraud; Meng Gu; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Neurobiol Aging       Date:  2012-10-30       Impact factor: 4.673

4.  Age-related differential sensitivity to MK-801-induced locomotion and stereotypy in C57BL/6 mice.

Authors:  Chunting Qi; Hong Zou; Ruizhong Zhang; Guoping Zhao; Meilei Jin; Lei Yu
Journal:  Eur J Pharmacol       Date:  2007-11-12       Impact factor: 4.432

5.  Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer's disease from dementia with Lewy bodies.

Authors:  John-Paul Taylor; Sean J Colloby; Ian G McKeith; David J Burn; David Williams; Jim Patterson; John T O'Brien
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02-13       Impact factor: 10.154

6.  Alzheimer's disease - not an exaggeration of healthy aging.

Authors:  Krishnendu Ghosh; Pratibha Agarwal; Greg Haggerty
Journal:  Indian J Psychol Med       Date:  2011-07

7.  Formation of cortical plasticity in older adults following tDCS and motor training.

Authors:  Alicia M Goodwill; John Reynolds; Robin M Daly; Dawson J Kidgell
Journal:  Front Aging Neurosci       Date:  2013-12-06       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.